Manufacturers/E.R. Squibb & Sons, L.L.C.

E.R. Squibb & Sons, L.L.C.

24 drugs in NADAC|0 Generic,24 Brand

E.R. Squibb & Sons, L.L.C. lists 24 NDCs in the CMS NADAC file (0 generic, 24 brand), at an average NADAC of $177.86 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

0G / 24B

Avg Price / Unit

$177.8589

$2.33 – $1471.09

Avg 7d Change

-0.01%

Across 14 drugs with changes

7d Activity

8↑6↓10 flat

of 24 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

apixaban market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

Corticosteroid therapeutic class

Review the broader class where E.R. Squibb & Sons, L.L.C. has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does E.R. Squibb & Sons, L.L.C. make?

E.R. Squibb & Sons, L.L.C. lists 24 NDCs in the CMS NADAC file — 0 generic and 24 brand products.

What is the average price of E.R. Squibb & Sons, L.L.C. drugs?

The average NADAC across E.R. Squibb & Sons, L.L.C.'s portfolio is $177.8589 per unit, ranging from $2.3256 to $1471.0864.

What types of drugs does E.R. Squibb & Sons, L.L.C. make?

E.R. Squibb & Sons, L.L.C. makes drugs across 9 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (5), Factor Xa Inhibitor (5), Protease Inhibitor (3), Cholinergic Muscarinic Agonist (3), Cholinergic Muscarinic Antagonist (3).

Has E.R. Squibb & Sons, L.L.C. had any drug recalls?

No FDA enforcement recalls are matched to E.R. Squibb & Sons, L.L.C. in the openFDA feed.

How has E.R. Squibb & Sons, L.L.C.'s pricing changed recently?

Over the past 7 days, 8 E.R. Squibb & Sons, L.L.C. products rose and 6 fell, with a portfolio-wide average change of -0.0%.

Drug Portfolio

24 drugs total, 24 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
ORENCIA CLICKJECT 125 MG/ML abatacept	00003218851	$1471.0864 per ML	+0.06%	Brand	—	Selective T Cell Costimulation Modulator
ORENCIA 125 MG/ML SYRINGE abatacept	00003218811	$1469.2280 per ML	+0.03%	Brand	—	Selective T Cell Costimulation Modulator
SPRYCEL 100 MG TABLET dasatinib	00003085222	$591.1812 per EA	—	Brand	High Outlier	Kinase Inhibitor
SPRYCEL 50 MG TABLET dasatinib	00003052811	$327.4239 per EA	—	Brand	High Outlier	Kinase Inhibitor
EVOTAZ 300 MG-150 MG TABLET atazanavir and cobicistat	00003364111	$52.0479 per EA	+0.06%	Brand	—	Cytochrome P450 3A Inhibitor, Protease Inhibitor
REYATAZ 300 MG CAPSULE ATAZANAVIR	00003362212	$46.9853 per EA	—	Brand	High Outlier	Protease Inhibitor
BARACLUDE 0.5 MG TABLET entecavir	00003161112	$44.1865 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
BARACLUDE 1 MG TABLET entecavir	00003161212	$43.9221 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
COBENFY 50 MG-20 MG CAPSULE xanomeline and trospium chloride	00003005060	$30.2312 per EA	-0.03%	Brand	—	Cholinergic Muscarinic Agonist, Cholinergic Muscarinic Antagonist
COBENFY 125 MG-30 MG CAPSULE xanomeline and trospium chloride	00003012560	$30.2302 per EA	-0.08%	Brand	—	Cholinergic Muscarinic Agonist, Cholinergic Muscarinic Antagonist
COBENFY 100 MG-20 MG CAPSULE xanomeline and trospium chloride	00003110060	$30.1319 per EA	-0.06%	Brand	—	Cholinergic Muscarinic Agonist, Cholinergic Muscarinic Antagonist
COBENFY STARTER PACK xanomeline and trospium chloride	00003520056	$30.0707 per EA	—	Brand	—	—
REYATAZ 200 MG CAPSULE ATAZANAVIR	00003363112	$23.6653 per EA	—	Brand	High Outlier	Protease Inhibitor
KENALOG-80 80 MG/ML VIAL TRIAMCINOLONE ACETONIDE	00003031505	$17.8667 per ML	+0.13%	Brand	—	Corticosteroid
KENALOG-40 200 MG/5 ML VIAL TRIAMCINOLONE ACETONIDE	00003029320	$9.1454 per ML	-0.21%	Brand	—	Corticosteroid
KENALOG-40 40 MG/ML VIAL TRIAMCINOLONE ACETONIDE	00003029305	$9.0018 per ML	+0.01%	Brand	—	Corticosteroid
KENALOG-40 400 MG/10 ML VIAL TRIAMCINOLONE ACETONIDE	00003029328	$6.7865 per ML	+0.04%	Brand	—	Corticosteroid
ELIQUIS 5 MG TABLET apixaban	00003089421	$5.5211 per EA	0.00%	Brand	—	Factor Xa Inhibitor
ELIQUIS 5 MG TABLET apixaban	00003089431	$5.5211 per EA	0.00%	Brand	—	Factor Xa Inhibitor
ELIQUIS 5 MG TABLET apixaban	00003089470	$5.5211 per EA	0.00%	Brand	—	Factor Xa Inhibitor
ELIQUIS 2.5 MG TABLET apixaban	00003089321	$5.5128 per EA	-0.10%	Brand	—	Factor Xa Inhibitor
ELIQUIS 2.5 MG TABLET apixaban	00003089331	$5.5128 per EA	-0.10%	Brand	—	Factor Xa Inhibitor
ELIQUIS DVT-PE TREATMENT 30-DAY STARTER 5 MG PACK apixaban	00003376474	$5.5077 per EA	+0.03%	Brand	—	—
KENALOG-10 50 MG/5 ML VIAL TRIAMCINOLONE ACETONIDE	00003049420	$2.3256 per ML	+0.14%	Brand	—	Corticosteroid